In particular, the HCC-causing oncogenic effect is mediated through persistent stimulation of IL-6, leading to the phosphorylation/activation of JAK2 followed by phosphorylation/activation of STAT3. This evidence concerns the gene IL6 and hepatocellular carcinoma.